NOVEMBER 9TH, 2012 – Spence and Co Ltd, Brockton MA, a smoked salmon company is voluntarily recalling New York-Style Nova Lox, 4oz, Code/Lot: 9720704 due to an abundance of caution because of possible contamination by Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant woman.
Read The Complete Story!
All posts by admin
Frito-Lay Issues Voluntary Recall of GRANDMA’S Peanut Butter Sandwich Creme Cookies and GRANDMA’s Peanut Butter Mini Sandwich Creme Cookies Due to Undeclared Milk and Egg
November 9, 2012 – PLANO, Texas – Frito-Lay announced the nationwide voluntary recall of GRANDMA’S Peanut Butter Sandwich Creme cookies and GRANDMA’S Peanut Butter Mini Sandwich Creme cookies because they contain undeclared milk and egg. People who have an allergy or severe sensitivity to milk or egg run the risk of a serious or life threatening allergic reaction if they consume the GRANDMA’S Peanut Butter Sandwich Creme and GRANDMA’S Peanut Butter Mini Sandwich Creme products.
Nestlé USA Announces Voluntary Recall of NESQUIK® Chocolate Powder
Nestlé USA announced the voluntary recall of limited quantities of Nestlé NESQUIK® Chocolate Powder in the 10.9, 21.8 and 40.7 ounce canisters. The voluntary recall is limited to only NESQUIK Chocolate Powder, which was distributed nationally. No other varieties of NESQUIK powder or any sizes or flavors of NESQUIK ready-to-drink are affected by this recall.
Fresh Express Recalls Limited Quantity of 9 oz. Spinach Due to Possible Health Risk
November 7, 2012 Charlotte, North Carolina – Fresh Express Incorporated is conducting a voluntary, precautionary recall of a limited quantity of Fresh Express Spinach with a Use-by Date of November 7 and Product Code of S299B25 due to a possible health risk from Salmonella.
Consumer Alert – Undeclared Sulfites In Fu Xiang Yuan Trading Inc "Lily Dry"
New York State Agriculture Commissioner Darrel J. Aubertine today alerted consumers that Mayflower International Inc, aka Fu Xiang Yuan Trading Inc, located at 220 Ingrahm St. in Brooklyn, NY, is recalling Fu Xiang Yuan Trading Inc brand “Lily Dry� due to the presence of undeclared sulfites. No illnesses have been reported to date to this Department in connection with this product.
Omya Voluntarily Recalls Ground Limestone Products Due to Possible Health Risk
Omya Inc. is voluntarily recalling certain lots of food grade ground limestone products processed at its Superior, Arizona plant because of the possible presence of Salmonella. There have been no reports of any illnesses or adverse health effects associated with any of Omya’s food grade ground limestone products.
Read The Complete Story!
FDA approves Xeljanz for rheumatoid arthritis
The U.S. Food and Drug Administration today approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to, or who are intolerant of, methotrexate.
Select Containers of Kroger Deluxe French Vanilla Ice Cream
The Kroger Co. (NYSE: KR) said today it is recalling select containers of Kroger Deluxe French Vanilla Ice Cream sold at the company’s Dillons, King Soopers/City Market, Fry’s Food and Smith’s Food & Drug operating divisions in 11 states because it may contain pecans not listed on the label.
Customers should return the product to stores for a full refund or replacement.
Read The Complete Story!
FDA warns Tennessee company that online product claims violate federal law
The U.S. Food and Drug Administration today issued a Warning Letter to The Avalon Effect Inc., a company based in Franklin, Tenn., for its marketing of a light therapy product that claims to cure or treat symptoms of fungal meningitis, methicillin-resistant Staphylococcus aureus (MRSA), concussions, Lyme disease, and other diseases.
FDA expands use of Xarelto to treat, reduce recurrence of blood clots
The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following initial treatment.